Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK6 | Q00534 | 17/20 | 0.69 |
| ▸ | CDK4 | P11802 | 15/20 | 0.69 |
| ▸ | CCND3 | P30281 | 13/20 | 0.69 |
| ▸ | CDK1 | P06493 | 11/20 | 0.69 |
| ▸ | CCNA2 | P20248 | 9/20 | 0.69 |
| ▸ | CDK2 | P24941 | 8/20 | 0.66 |
| ▸ | CDK7 | P50613 | 3/20 | 0.66 |
| ▸ | CDK9 | P50750 | 3/20 | 0.66 |
| ▸ | PIM1 | P11309 | 5/20 | 0.65 |
| ▸ | CCNE2 | O96020 | 5/20 | 0.65 |
| ▸ | CCND1 | P24385 | 4/20 | 0.65 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.65 |
| ▸ | EGFR | P00533 | 2/20 | 0.65 |
| ▸ | CIT | O14578 | 1/20 | 0.65 |
| ▸ | GAK | O14976 | 1/20 | 0.65 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.65 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.65 |
| ▸ | STK16 | O75716 | 1/20 | 0.65 |
| ▸ | CCNK | O75909 | 1/20 | 0.65 |
| ▸ | STK10 | O94804 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17488831 | 1.00 | CDK6 (0.69) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL30459609 | 1.00 | CDK6 (0.69) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL30459527 | 0.93 | CDK4 (0.62) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17489268 | 0.93 | CDK4 (0.62) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17488648 | 0.93 | CDK4 (0.68) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17489251 | 0.91 | CDK4 (0.60) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17488826 | 0.91 | CDK4 (0.67) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17485303 | 0.91 | CDK4 (0.68) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17488855 | 0.91 | CDK4 (0.70) | CDK6CDK4CCND3CDK1CCNA2 | |
| SCHEMBL17488811 | 0.91 | CDK4 (0.70) | CDK6CDK4CCND3CDK1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446324-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023104155-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | 标新生物医药科技(上海)有限公司 | 2023-06-15 | — | — | WO | disclosed |